The Polish market for clinical trials saw an estimated 7% year-on-year growth in 2011, after relatively flat periods in 2009 and 2010. Experts predict that the Polish market's year-to-year expansion will hover around 3% and 4% in 2012 and 2013. The moderate growth indicates that the country remains an attractive destination for clinical trials and research. Story